Literature DB >> 15980068

Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication.

Sarah Welbourn1, Robin Green, Isabelle Gamache, Serge Dandache, Volker Lohmann, Ralf Bartenschlager, Karen Meerovitch, Arnim Pause.   

Abstract

The hepatitis C virus NS2/3 protease is responsible for cleavage of the viral polyprotein between nonstructural proteins NS2 and NS3. We show here that mutation of three highly conserved residues in NS2 (His(952), Glu(972), and Cys(993)) abrogates NS2/3 protease activity and that introduction of any of these mutations into subgenomic NS2-5B replicons results in complete inactivation of NS2/3 processing and RNA replication in both stable and transient replication assays. The effect of uncleaved NS2 on the various activities of NS3 was therefore explored. Unprocessed NS2 had no significant effect on the in vitro ATPase and helicase activities of NS3, whereas immunoprecipitation experiments demonstrated a decreased affinity of NS4A for uncleaved NS2/3 as compared with NS3. This subsequently resulted in reduced kinetics in an in vitro NS3 protease assay with the unprocessed NS2/3 protein. Interestingly, NS3 was still capable of efficient processing of the polyprotein expressed from a subgenomic replicon in Huh-7 cells in the presence of uncleaved NS2. Notably, we show that fusion with NS2 leads to the rapid degradation of NS3, whose activity is essential for RNA replication. Finally, we demonstrate that uncleaved NS2/3 degradation can be prevented by the addition of a proteasome inhibitor. We therefore propose that NS2/3 processing is a critical step in the viral life cycle and is required to permit the accumulation of sufficient NS3 for RNA replication to occur. The regulation of NS2/3 cleavage could constitute a novel mechanism of switching between viral RNA replication and other processes of the hepatitis C virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980068     DOI: 10.1074/jbc.M505019200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Conformational stability of hepatitis C virus NS3 protease.

Authors:  Olga Abian; Sonia Vega; Jose Luis Neira; Adrian Velazquez-Campoy
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

2.  Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3.

Authors:  V Schregel; S Jacobi; F Penin; N Tautz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

3.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

4.  Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein.

Authors:  Cynthia de la Fuente; Zachary Goodman; Charles M Rice
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

6.  Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus.

Authors:  Thomas G Dentzer; Ivo C Lorenz; Matthew J Evans; Charles M Rice
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

7.  Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.

Authors:  Christopher T Jones; Catherine L Murray; Dawnnica K Eastman; Jodie Tassello; Charles M Rice
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

8.  Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Authors:  Peiyong Huang; Dane A Goff; Qi Huang; Anthony Martinez; Xiang Xu; Scott Crowder; Sarkiz D Issakani; Emily Anderson; Ning Sheng; Philip Achacoso; Ann Yen; Todd Kinsella; Ihab S Darwish; Rao Kolluri; Hui Hong; Kunbin Qu; Emily Stauffer; Eileen Goldstein; Rajinder Singh; Donald G Payan; H Henry Lu
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

9.  Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.

Authors:  Artur Kaul; Sarah Stauffer; Carola Berger; Thomas Pertel; Jennifer Schmitt; Stephanie Kallis; Margarita Zayas; Margarita Zayas Lopez; Volker Lohmann; Jeremy Luban; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

10.  Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.